Drug Type Small molecule drug |
Synonyms- |
Target |
Action agonists |
Mechanism GPR40 agonists(Free fatty acid receptor 1 agonists) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
License Organization- |
Drug Highest PhasePendingPreclinical |
First Approval Date- |
Regulation- |
Molecular FormulaC27H25ClN2O3 |
InChIKeyGFFXCPIMXLSUGF-VWLOTQADSA-N |
CAS Registry916219-50-6 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Diabetes Mellitus, Type 2 | Preclinical | United States | 01 Jan 2016 |